Use of Palliative Care in Managing Genitourinary Malignancies May Vary Across the United States
Patients with GU malignancies were more likely to receive palliative care if they were in the West compared with other US regions.
Patients with GU malignancies were more likely to receive palliative care if they were in the West compared with other US regions.
Pembrolizumab, a PD-1 inhibitor, demonstrated antitumor activity in patients with high-risk BCG-unresponsive carcinoma in situ.
Health care providers ordering meds should view ‘too good to be true’ offers with suspicion, agency says.